5 Key Takeaways
-
1
An 87-year-old male with advanced dry AMD and bilateral geographic atrophy was treated with an intravitreal complement inhibitor.
-
2
Early intervention maintained the patient's visual acuity and independence, allowing him to continue driving and caregiving.
-
3
The complement inhibitor treatment slowed the growth of geographic atrophy lesions by approximately 20% to 30% over time.
-
4
Flexible dosing intervals of 6 to 8 weeks facilitated adherence to treatment while balancing efficacy and patient burden.
-
5
This case highlights the importance of early bilateral therapy in managing geographic atrophy and preserving quality of life.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.







